Interestingly, in this context, the loss of CAV1 expression in breast cancer tumor–stroma reportedly induces HIF1α activation [28] and the loss of CAV1 in stromal cells leads to a glycolytic and catabolic phenotype through HIF1α stabilization, favoring synergy with oxidative breast cancer cells [29]. The gene discussed is HIF1A; the disease is breast carcinoma.